Journal of the National Cancer Institute Advance Access originally published online on October 9, 2007
JNCI Journal of the National Cancer Institute 2007 99(20):1507-1509; doi:10.1093/jnci/djm193
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
NEWS |
Radioactive "Seed" Implants May Rival Surgery for Low-Risk Prostate Cancer Patients
| The first 150 words of the full text of this article appear below. |
Implanted radioactive " seeds" offer low-risk prostate cancer patients a minimally invasive treatment option that some investigators think could be as effective as surgical removal of the prostate if placed by experienced radiation oncologists, according to a series of recent studies.
| |||||||||||
Prostate cancer is the most frequently diagnosed cancer in men, and patients who receive the diagnosis often have several treatment options. The three most common treatments—radical prostatectomy, external-beam radiation, and implantation of radioactive isotope seeds—offer similar survival rates for low-risk patients (though they have not been compared directly in randomized trials). But until recently, few studies had been available to help patients and their doctors choose the best treatment for them. New reports suggest that minimally invasive options such as brachytherapy are associated with good long-term survival
Quality-of-Life Issues
Looking to the Future